Mucin-induced apoptosis of monocyte-derived dendritic cells during maturation

Proteomics

Volumn 8, Issue 16, 2008, Pages 3342-3349

  Ishida, Akiko ^a   Ohta, Mariko ^b   Toda, Munetoyo ^b   Murata, Takeomi ^c   Usui, Taichi ^c   Akita, Kaoru ^a   Inoue, Mizue ^b   Nakada, Hiroshi ^a,b  

^a KYOTO SANGYO UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c SHIZUOKA UNIVERSITY   (Japan)

Author keywords

Apoptosis; Dendritic cell; Mucin; Siglec 3; Tumor

Indexed keywords

GLYCAN DERIVATIVE; LECTIN; MONOCLONAL ANTIBODY; MUCIN; MUCIN 2; RECOMBINANT PROTEIN; SIALIC ACID BINDING IMMUNOGLOBULIN LIKE LECTIN 3; SIALIC ACID DERIVATIVE; TN ANTIGEN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BINDING SITE; CELL MATURATION; DENDRITIC CELL; HUMAN; HUMAN CELL; LECTIN BINDING; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION;

ANTIBODIES, MONOCLONAL; APOPTOSIS; CELL DIFFERENTIATION; CELL LINE, TUMOR; DENDRITIC CELLS; FLOW CYTOMETRY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-4; LECTINS; MONOCYTES; MUCIN-2; PROTEIN BINDING; RECOMBINANT PROTEINS; U937 CELLS;

EID: 50449091524     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200800039     Document Type: Article

References (29)

1. Miyake, M., Taki, T., Hitomi, S., Hakomori, S., Correlation of expression of H/Le(y)/Le(b) antigens with survival in patients with carcinoma of the lung. N. Engl. J. Med. 1992, 327, 14-18.
2. Crocker, P. R., Paulson, J. C., Varki, A., Siglecs and their roles in the immune system. Nat. Rev. Immunol. 2007, 7, 255-266.
3. Ravetch, J. V., Lanier, L. L., Immune inhibitory receptor. Science 2000, 290, 84-89.
4. Chouaib, S., Asselin-Paturel, C., Mami-Chouaib, F., Caignard, A., Blay, J. Y., The host-tumor immune conflict: From immunosuppression to resistance and destruction. Immunol. Today 1997, 18, 493-497.
5. Botti, C., Seregni, E., Ferrari, L., Martinetti, A., Bombardieri, E., Immunosuppressive factors: Role in cancer development and progression. Int. J. Biol. Markers 1998, 13, 51-69.
6. Hart, D. N., Dendritic cells: Unique leukocyte populations which control the primary immune response. Blood 1997, 90, 3245-3287.
7. Banchereau, J., Steinman, R. M., Dendritic cells and the control of immunity. Nature 1998, 392, 245-252.
8. Almand, B., Clark, J. I., Nikitina, E., van Beynen, J. et al., Increased production of immature myeloid cells in cancer patients: A mechanism of immunosuppression in cancer. J. Immunol. 2001, 166, 678-689.
9. Bell, D., Chomarat, P., Broyles, D., Netto, G. et al., In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral area. J. Exp. Med. 1999, 190, 1417-1426.
10. Thomachot, M. C., Bendriss-Vermare, N., Massacrier, C., Biota, C. et al., Breast carcinoma cells promote the differentiation of CD34+ progenitors towards 2 different subpopulations of dendritic cells with CD1a(high) CD86(-) Langerin- and CD1a (+) CD86 (+) Langerin+ phenotypes. Int. J. Cancer 2004, 110, 710-720.
11. Rughetti, A., Pellicciotta, I., Biffoni, M., Backstrom, L. et al., Recombinant tumor-associated MUC1 glycoprotein impairs the differentiation and function of dendritic cells. J. Immunol. 2005, 174, 7764-7772.
12. Kiertscher, S. M., Luo, J., Dubinett, S. M., Roth, M. D., Tumors promote altered maturation and early apoptosis of monocyte-derived dendritic cells. J. Immunol. 2000, 164, 1269-1276.
13. a oligosaccharide, but is distinct from NS 19-9 as to epitope recognition. J. Biochem. 1988, 104, 817-821.
14. Tanaka, N., Nakada, H., Inoue, M., Yamashina, I., Binding characteristics of an anti-Siaα2-6GalNAcα-Ser/Thr (sialyl Tn) monoclonal antibody (MLS 132). Eur. J. Biochem. 1999, 263, 27-32.
15. Numata, Y., Nakada, H., Fukui, S., Kitagawa, H. et al., A monoclonal antibody directed to Tn antigen. Biochem. Biophys. Res. Commun. 1990, 170, 981-985.
16. Totani, K., Kubota, T., Kuroda, T., Murata, T. et al., Chemoenzymatic synthesis and application of glycopolymers containing multivalent sialyloligosaccharides with a poly (L-glutamic acid) backbone for inhibition of infection by influenza cviruses. Glycobiology 2003, 13, 315-326.
17. Dauer, M., Obermaier, B., Hertern, J., Haerle, C. et al., Mature dendritic cells derived from human monocytes within 48 hours: A novel strategy for dendritic cell differentiation from blood precursors. J. Immunol. 2003, 170, 4069-4076.
18. Inaba, T., Sano, H., Kawahito, Y., Hla, T. et al., Induction of cyclooxygenase-2 in monocyte/macrophage by mucins secreted from colon cancer cells. Proc. Natl. Acad. Sci. USA 2003, 100, 2736-2741.
19. McCool, D. J., Forstner, J. F., Forstner, G. G., Synthesis and secretion of mucin by the human colonic tumour cell line LS180. Biochem. J. 1994, 302, 111-118.
20. Blixt, O., Collins, B. E., van den Nieuwenhof, I. M., Crocker, P. R., Paulson, J. C., Sialoside specificity of the siglec family assessed using novel multivalent probes: Identification of potent inhibitors of myelin-associated glycoprotein. J. Biol. Chem. 2003, 278, 31007-31019.
21. Zeid, N. A., Muller, H. K., S100 positive dendritic cells in human lung tumors associated with cell differentiation and enhanced survival. Paffiology 1993, 25, 338-343.
22. Chaux, P., Favre, N., Martin, M., Martin, F., Tumor-infiltrating dendritic cells are defective in their antigen-presenting function and inducible B7 expression in rats. Int. J. Cancer 1997, 72, 619-624.
23. Gabrilovich, D. I., Corak, J., Ciernik, I. F., Kavanaugh, D., Carbone, D. P., Decreased antigen presentation by dendritic cells in patients with breast cancer. Clin. Cancer Res. 1997, 3, 483-490.
24. Enk, A. H., Jonuleit, H., Saloga, J., Knop, J., Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma. Int. J. Cancer 1997, 73, 309-316.
25. Pequet-Navarro, J., Sportouch, M., Popa, I., Berithier, O. et al., Gangliosides from human melanoma tumors impair dendritic cell differentiation from monocytes and induce their apoptosis. J. Immunol. 2003, 170, 3488-3494.
26. Della Bella, S., Bennaro, M., Vaccari, M., Ferraris, C. et al., Altered maturation of peripheral blood dendritic cells in patients with breast cancer. Br. J. Cancer 2003, 89, 1463-1472.
27. low regulatory dendritic cell. J. Immunol. 2004, 172, 7341-7349.
28. Apostolopoulos, V., Loveland, B. E., Pietersz, G. A., McKenzie, I. F., CTL in mice immunized with human mucin 1 are MHC-restricted. J. Immunol. 1995, 155, 5089-5094.
29. Apostolopoulos, V., Pietersz, G. A., Mckenzie, I. F., Cell-mediated immune responses to MUC1 fusion protein coupled to mannan. Vaccine 1996, 14, 930-938.